Trial · NCT01116882
Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings
NCT01116882, Not applicable, Completed, Baim Institute for Clinical Research; results first posted 2014-07-08
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings. Trials, record NCT01116882. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01116882
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings
- NCT number
- NCT01116882
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 3,691 participants, actual
- Lead sponsor
- Baim Institute for Clinical Research
- Conditions
- Coronary Artery Diseases
- Interventions
- PCI
- First posted
- 2010-05-05
- Last updated
- 2015-04-07
- Results first posted
- 2014-07-08
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 30-day Composite Major Adverse Cardiac Event (MACE) | 30 days | |
| Primary | 12-month Composite Major Adverse Cardiac Event (MACE) | 12 month | |
| Secondary | All Cause Mortality at 30 Days | 30 days | |
| Secondary | Ischemia-driven Target Lesion Revascularization | 30 days | |
| Secondary | Ischemia-driven Target Lesion Revascularization | 12 months | |
| Secondary | Rate of Stent Thrombosis | 12 months | |
| Secondary | Any Repeat Revascularization | 12 months | |
| Secondary | Emergency or Urgent Revascularization | 30 days | |
| Secondary | Procedural Success | Post-Procedure | Procedural success is defined as residual stenosis of the target lesion of less than 20% |
| Secondary | Major Vascular Complications | 30 days |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | 30-day Composite Major Adverse Cardiac Event (MACE) | 30 days | The denominator for MACE at 30 days is defined as patients who either had MACE to 30d or had follow up of at least 23 days. | participants | NUMBER |
| PRIMARY | 12-month Composite Major Adverse Cardiac Event (MACE) | 12 month | participants | NUMBER | |
| SECONDARY | All Cause Mortality at 30 Days | 30 days | The denominator for MACE at 30 days is defined as patients who either died to 30d or had follow up of at least 23 days. | participants | NUMBER |
| SECONDARY | Ischemia-driven Target Lesion Revascularization | 30 days | participants | NUMBER | |
| SECONDARY | Ischemia-driven Target Lesion Revascularization | 12 months | participants | NUMBER | |
| SECONDARY | Rate of Stent Thrombosis | 12 months | participants | NUMBER | |
| SECONDARY | Any Repeat Revascularization | 12 months | participants | NUMBER | |
| SECONDARY | Emergency or Urgent Revascularization | 30 days | The denominator for emergency or urgent revascularization at 30 days is defined as patients who either had the event to 30d or had follow up of at least 23 days. | participants | NUMBER |
| SECONDARY | Procedural Success | Post-Procedure | participants | NUMBER | |
| SECONDARY | Major Vascular Complications | 30 days | participants | NUMBER |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 outcomesResults by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| 30-day Composite Major Adverse Cardiac Event (MACE) | PCI at Hospitals Without On-Site Cardiac Surgery | 256 | participants | ||
| 30-day Composite Major Adverse Cardiac Event (MACE) | PCI at Hospital With On-Site Cardiac Surgery | 83 | participants | ||
| 12-month Composite Major Adverse Cardiac Event (MACE) | PCI at Hospitals Without On-Site Cardiac Surgery | 421 | participants | ||
| 12-month Composite Major Adverse Cardiac Event (MACE) | PCI at Hospital With On-Site Cardiac Surgery | 140 | participants | ||
| All Cause Mortality at 30 Days | PCI at Hospitals Without On-Site Cardiac Surgery | 18 | participants | ||
| All Cause Mortality at 30 Days | PCI at Hospital With On-Site Cardiac Surgery | 3 | participants | ||
| Ischemia-driven Target Lesion Revascularization | PCI at Hospitals Without On-Site Cardiac Surgery | 36 | participants | ||
| Ischemia-driven Target Lesion Revascularization | PCI at Hospital With On-Site Cardiac Surgery | 12 | participants | ||
| Ischemia-driven Target Lesion Revascularization | PCI at Hospitals Without On-Site Cardiac Surgery | 117 | participants | ||
| Ischemia-driven Target Lesion Revascularization | PCI at Hospital With On-Site Cardiac Surgery | 38 | participants |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 results by groupParticipant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 30-day | STARTED | PCI at a Hospital Without On-site Cardiac Surgery | 2,774 | |
| 30-day | STARTED | PCI at Hospital With On-Site Cardiac Surgery | 917 | |
| 30-day | COMPLETED | PCI at a Hospital Without On-site Cardiac Surgery | 2,706 | |
| 30-day | COMPLETED | PCI at Hospital With On-Site Cardiac Surgery | 886 | |
| 30-day | NOT COMPLETED | PCI at a Hospital Without On-site Cardiac Surgery | 68 | |
| 30-day | NOT COMPLETED | PCI at Hospital With On-Site Cardiac Surgery | 31 | |
| 12-month | STARTED | PCI at a Hospital Without On-site Cardiac Surgery | 2,706 | |
| 12-month | STARTED | PCI at Hospital With On-Site Cardiac Surgery | 886 | |
| 12-month | COMPLETED | PCI at a Hospital Without On-site Cardiac Surgery | 2,439 | |
| 12-month | COMPLETED | PCI at Hospital With On-Site Cardiac Surgery | 787 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Non-Surgery-On-Site (Non-SOS) | ||
| Total, all-cause mortality | Surgery-On-Site (SOS) | ||
| Total, other adverse events | Non-Surgery-On-Site (Non-SOS) | 0 | 0 |
| Total, other adverse events | Surgery-On-Site (SOS) | 0 | 0 |
| Total, serious adverse events | Non-Surgery-On-Site (Non-SOS) | 0 | 0 |
| Total, serious adverse events | Surgery-On-Site (SOS) | 0 | 0 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons16
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Complete Revascularization | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Procedural Success | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: 30-day Composite Major Adverse Cardiac Event (MACE) | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Rate of Stent Thrombosis | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Ischemia-driven Target Vessel Revascularization | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: All Cause Mortality at 30 Days | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Any Repeat Revascularization | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Any Repeat Revascularization | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Ischemia-driven Target Vessel Revascularization | Trial comparisons |
| PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: All Cause Mortality at 12 Months | Trial comparisons |
1 to 10 of 16
See all 16 trial comparisonsTests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01116882
GET https://conductscience.org/api/trials/v1/NCT01116882/results?page=2